Keyword Connections

Busulfan

Journals

3

1 Cancers

2 erzincan Üniversitesi fen bilimleri enstitüsü dergisi

3 biology of blood and marrow transplantation : journal of the american society for blood and marrow transplantation

Research Groups

0

No Research Group Connected

Bibliographies

14

1 Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency.

2 Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review.

3 Antikanser İlaç Etken Madde Busulfana Seçici Katı-Hal PVC Membran Potansiyometrik Mikrosensör

4 Antikanser İlaç Etken Madde Busulfana Seçici Katı-Hal PVC Membran Potansiyometrik Mikrosensör

5 Antikanser İlaç Etken Madde Busulfana Seçici Katı-Hal PVC Membran Potansiyometrik Mikrosensör

6 Limited Sampling Strategies Supporting Individualized Dose Adjustment of Intravenous Busulfan in Children and Young Adults.

7 Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.

8 Determination of tetrahydrothiophene formation as a probe of in vitro busulfan metabolism by human glutathione S-transferase A1-1: use of a highly sensitive gas chromatographic-mass spectrometric method.

9 Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling.

10 Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.

11 High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.

12 High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.

13 High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.

14 Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.